Federation des caisses Desjardins du Quebec’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37 Hold
35
﹤0.01% 2982
2026
Q1
$40 Hold
35
﹤0.01% 2925
2025
Q4
$38 Hold
35
﹤0.01% 2839
2025
Q3
$35 Hold
35
﹤0.01% 2840
2025
Q2
$40 Hold
35
﹤0.01% 2692
2025
Q1
$52 Buy
+35
New +$42 ﹤0.01% 2622

Other funds holding LUCD

Federation des caisses Desjardins du Quebec's LUCD Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Lucid Diagnostics (LUCD) position steady in Q2 2026 at 35 shares worth $37. The position accounts for ﹤0.01% of the portfolio, ranked #2982.

Federation des caisses Desjardins du Quebec first reported a position in LUCD in Q1 2025 and has held it in 6 quarters since. The position peaked at $52 in Q1 2025. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 35 shares of Lucid Diagnostics worth $37 as of Q2 2026.
  • Federation des caisses Desjardins du Quebec left its Lucid Diagnostics share count unchanged in Q2 2026.
  • Lucid Diagnostics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2982 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Lucid Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • Federation des caisses Desjardins du Quebec's Lucid Diagnostics position peaked at $52 in Q1 2025.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.